![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
No decline in hepatitis C incidence among HIV-positive MSM;
an update from
the CASCADE Collaboration
|
|
|
Reported by Jules Levin
EACS 2015 Oct 21-24 Barcelona, Spain
Daniela K. van Santen, on behalf of the CASCADE Collaboration in EuroCoord
"We observed a significant rise of the HCV incidence over calendar years (p<0.001) with no decline observed in recent years; ranging from 0.7 (95%CI=0.1-5) in 1990 to 18 (95%CI=9-35) in 2014 per 1,000 py in method 1 (Figure 1)......Trends differ by geographical region; in recent years, HCV incidence seems to be increasing in Southern and Northern Europe whereas in Western Europe, HCV incidence seems to be stabilizing (not shown)."
![EACS1.gif](../images/103015/103015-4/EACS1.gif)
![EACS2.gif](../images/103015/103015-4/EACS2.gif)
![EACS3.gif](../images/103015/103015-4/EACS3.gif)
![EACS4.gif](../images/103015/103015-4/EACS4.gif)
![EACS5.gif](../images/103015/103015-4/EACS5.gif)
![EACS6.gif](../images/103015/103015-4/EACS6.gif)
![EACS7.gif](../images/103015/103015-4/EACS7.gif)
![EACS8.gif](../images/103015/103015-4/EACS8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|